The pharmaceutical landscape witnessing a revolution with the emergence of novel glucagon-like peptide-1 (GLP-1) receptor agonists. These innovative drugs demonstrate immense potential in managing type 2 diabetes and, https://keithomsn980741.wikipublicist.com/5456191/novel_glp_1_receptor_agonists_retatrutide_cagrillintide_tirzepatide_and_semaglutide